Indoco Remedies Ltd. has received a major reprieve as the GST Authority officially dropped proceedings against the company, withdrawing a potential tax demand of ₹85 million. The decision follows Indoco’s response to a Show Cause Notice (SCN) issued in August 2024, which questioned input tax credit claims and GSTR9C reconciliation issues.
Key Highlights:
-
Regulatory Clearance: The GST Authority’s February 2025 order confirmed that Indoco’s tax filings were in compliance, leading to the withdrawal of the demand.
-
Background of the Case: Indoco was initially served a SCN on August 22, 2024, citing concerns over excess input tax credit claims and reconciliation discrepancies.
-
Legal Response: The company submitted clarifications, demonstrating that the alleged violations were procedural rather than substantive.
-
Financial Impact: With the proceedings dropped, Indoco avoids a significant financial liability, ensuring business continuity and investor confidence.
-
Market Reaction: Analysts view this as a positive development, reinforcing Indoco’s strong compliance framework and regulatory transparency.
This resolution removes a major regulatory hurdle, allowing Indoco Remedies to focus on growth and operational expansion without taxrelated uncertainties.
Sources: Indoco Remedies Official Statement, Economic Times